Influence of low-intensity anticoagulation and low-dose antiplatelet agent on coagulation-fibrinolysis system after mechanical prosthetic valve replacement.
Moriyama
Y
Y
Department of Surgery, Kagoshima University, Faculty of Medicine, Kagoshima City, Japan.
Nakamura
K
K
Kariyazono
H
H
Toyohira
H
H
Taira
A
A
D000925:Anticoagulants / Q000008:administration & dosage* / Q000627:therapeutic use; D001021:Aortic Valve; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects*; D001807:Blood Vessel Prosthesis; D005260:Female; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D011182:Postoperative Care; D013988:Ticlopidine / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D013988:Ticlopidine; D001241:Aspirin